Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Featuring perspectives from Dr Terence Friedlander, Dr Matthew
Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr
Friedlander, including the following topics:
Case: A man in his early 80s with non-muscle-invasive bladder
cancer (NMIBC) monitored by repeat TURBTs develops localized
muscle-invasive bladder cancer and enrolls in a clinical trial of
neoadjuvant enfortumab vedotin with pembrolizumab (0:00)
Case: A man in his late 70s with newly diagnosed NMIBC with
carcinoma in situ (CIS) receives BCG induction and experiences
relapse of CIS during BCG maintenance (9:24)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.